Title : Sickle cell acute chest syndrome: pathogenesis and rationale for treatment.

Pub. Date : 1999 Sep 1

PMID : 10477680






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Our investigations also provide a rationale for the therapeutic use in ACS of cytoprotective modulators including NO and dexamethasone, which potentially exert their efficacy by an inhibitory effect on VCAM-1 and concomitant inhibition of sickle erythrocyte-endothelial adhesion. Dexamethasone vascular cell adhesion molecule 1 Homo sapiens